Want to create an interactive transcript for this episode?
Podcast: Surfing the MASH Tsunami
Episode: S3-E25.4 - NASH Drug Development in 2022: Will Quality of Life Data Help NASH Drugs Over the Finish Line?
Description: Louise Campbell starts this discussion by citing her sources of optimism about NASH drug development: (i) the high likelihood of getting a drug to market over the next couple of years, which will lead to better education of patients and providers alike; (ii) FDA looking for more inclusion and diversity about drug trials, which will provide even more information for historically underserved populations; and (iii) in her observations and work, patients already are becoming more aware about Fatty Liver disease and the importance of treating it.From there, the conversation turns to consider what drug development has...